CODOFEN TABLET

Valsts: Kanāda

Valoda: angļu

Klimata pārmaiņas: Health Canada

Nopērc to tagad

Lejuplādēt Produkta apraksts (SPC)
15-04-2009

Aktīvā sastāvdaļa:

HYDROCODONE BITARTRATE; IBUPROFEN

Pieejams no:

PALADIN LABS INC.

ATĶ kods:

N02AJ23

SNN (starptautisko nepatentēto nosaukumu):

HYDROCODONE AND IBUPROFEN

Deva:

7.5MG; 200MG

Zāļu forma:

TABLET

Kompozīcija:

HYDROCODONE BITARTRATE 7.5MG; IBUPROFEN 200MG

Ievadīšanas:

ORAL

Vienības iepakojumā:

25/100/500

Receptes veids:

Narcotic (CDSA I)

Ārstniecības joma:

OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS

Produktu pārskats:

Active ingredient group (AIG) number: 0240381001; AHFS:

Autorizācija statuss:

CANCELLED PRE MARKET

Autorizācija datums:

2018-07-17

Produkta apraksts

                                PRODUCT MONOGRAPH
N
CODOFEN
®
(Hydrocodone bitartrate 7.5 mg-Ibuprofen 200 mg)
Tablets
_Opioid/NSAID combination analgesic_
Paladin Labs Inc.
DATE OF PREPARATION:
6111 Royalmount Avenue, Suite 102
April 14, 2009
Montreal (QC) Canada
H4P 2T4
Control No: 128830
−
1
−
PRODUCT MONOGRAPH
NAME OF DRUG
N
CODOFEN
®
(Hydrocodone bitartrate 7.5 mg-Ibuprofen 200 mg )
Tablets
THERAPEUTIC CLASSIFICATION
Opioid/NSAID combination analgesic
ACTION AND CLINICAL PHARMACOLOGY
HYDROCODONE COMPONENT
Hydrocodone is a centrally acting semisynthetic opioid antitussive and
analgesic. The precise
mechanism of analgesic action of hydrocodone and other opioids is not
known, although it is
believed to relate to the existence of opiate receptors in the central
nervous system. In addition
to analgesia, opioids may produce drowsiness, changes in mood, mental
clouding, constipation
and, in overdose, respiratory depression.
IBUPROFEN COMPONENT
Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that
possesses analgesic and
antipyretic activities. The mode
of action, like that of other NSAIDs, is not completely
understood, but may be related to inhibition of cyclooxygenase
activity and prostaglandin
synthesis. Ibuprofen is a peripherally acting analgesic. Ibuprofen
does not have any known
effects on opiate receptors.
CODOFEN combines the analgesic effects of the centrally acting
analgesic hydrocodone with
the peripherally acting NSAID analgesic, ibuprofen.
PHARMACOKINETICS
Hydrocodone bitartrate and ibuprofen are well absorbed in the
gastrointestinal tract from oral
CODOFEN. In a single oral dose study, 31 adult male and female
subjects dosed with two
CODOFEN tablets gave a mean hydrocodone C
max
of 27.3 ng/mL occurring at T
max
1.7 hours;
the mean half-life was 4.5 hours and the mean AUC
0-
∞
was 216 ng/mL*hr. The mean ibuprofen
−
2
−
C
max
was 30.2 mcg/mL occurring at T
max
1.8 hours; the mean half-life was 2.2 hours and the
mean AUC
0-
∞
was 136 mcg/mL*hr.
Hydrocodone
exhibits
a
complex
pattern
of
metabolism
including
O-dem
                                
                                Izlasiet visu dokumentu
                                
                            

Meklēt brīdinājumus, kas saistīti ar šo produktu

Skatīt dokumentu vēsturi